A Study Regarding the Risk Factors for Lymph node Metastasis of Gastric Adenocarcinoma of Fundic Gland type

A Retrospective Multicenter Study Regarding the Risk Factors for Lymph node Metastasis of Gastric Adenocarcinoma of Fundic Gland type - RESECT-GAFG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053226

Enrollment

130

Registered

2023-12-28

Start date

2023-12-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Adenocarcinoma of Fundic Gland type

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent surgical or endoscopic resection at participating institutions between January 1, 2010 and December 31, 2020, and were histologically diagnosed as gastric adenocarcinoma of fundic gland type (e.g., gastric adenocarcinoma of fundic gland type, gastric adenocarcinoma of fundic gland mucosal type) with a confirmed depth of submucosal invasion.

Exclusion criteria

Exclusion criteria: Patients with a history of cancer of the stomach or other organs within 3 years of surgery. However, the following cancers, which are considered to have almost no chance of having metastasis, are not included in the exclusion criteria 1) EP/LPM cancer of the esophagus 2) M cancer of the colon 3) Differentiated M carcinoma of the stomach less than 2 cm without ulcerative changes

Design outcomes

Primary

Measure	Time frame
Risk of lymph node metastasis and recurrence rate after 3 years of treatment in gastric cancer of the fundic gland type, especially submucosal invasive cancer (SM cancer).	—

Countries

Japan

Contacts

Public ContactRyohei Miyata

The University of Tokyo Hospital Gastroenterology

mrh306@g.ecc.u-tokyo.ac.jp03-3815-5411

Outcome results